Monroe Capital was the sole lead arranger and administrative agent for a $20 million senior credit facility funding to sponsor Cytovance Biologics' growth.
The growth is by private equity sponsor Great Point Partners. Cytovance is based in Oklahoma City and is a contract manufacturing organization of mammalian and microbial biologics. Cytovance supports customers from clinical development to commercial launch in domestic and international markets.
In June, Monroe Capital received funding for $15.5 million senior secured credit facility to support the acquisition of Employee Benefit Solutions by Pharos Capital Group.